drugset / Trial / NCT00282048
Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the activity and response rate of AG-013736 in patients with advanced and refractory renal cell cancer, (patients who also failed on sorafenib-based therapy).
Timeline
- Start
- 2006-03
- Primary completion
- 2009-02
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 5 mg | — |